Albuminuria and cognitive decline in people with diabetes and normal renal function

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 11, 2013, Pages 1907-1914

  Barzilay, Joshua I ^a   Lovato, James F ^a   Murray, Anne M ^a   Williamson, Jeff ^a   Ismail Beigi, Faramaz ^a   Karl, Diane ^a   Papademetriou, Vasilios ^a   Launer, Lenore J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALBUMINURIA; ARTICLE; BLOOD GLUCOSE MONITORING; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INFORMATION PROCESSING; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VERBAL MEMORY;

AGED; ALBUMINURIA; COGNITION; COGNITION DISORDERS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LOGISTIC MODELS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84887302167     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11321112     Document Type: Article

References (42)

1. Cukierman T, Gerstein HC, Williamson JD: Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469, 2005
2. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB: Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69: 1170-1175, 2012
3. Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer A, Kuller LH: Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J AmSoc Nephrol 15: 1904-1911, 2004
4. Murray AM, Knopman DS: Cognitive impairment in CKD: no longer an occult burden. Am J Kidney Dis 56: 615-618, 2010
5. Davey A, EliasMF, Robbins MA, Seliger SL, Dore GA: Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory [published online ahead of print November 18, 2012]. Nephrol Dial Transplant doi:10.1093/ndt/gfs470
6. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
7. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
8. Barzilay JI, Gao P, O'DonnellM, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S; ONTARGET and TRANSCEND Investigators: Albuminuria and decline in cognitive function: TheONTARGET/TRANSCEND studies. Arch Intern Med 171: 142-150, 2011
9. Murray AM, Barzilay JI, Lovato JF, Williamson JD, Miller ME, Marcovina S, Launer LJ; Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Substudy Investigators: Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 34: 1827-1832, 2011
10. Barzilay JI, Fitzpatrick AL, Luchsinger J, Yasar S, Bernick C, Jenny NS, Kuller LH: Albuminuria and dementia in the elderly: A community study. Am J Kidney Dis 52: 216-226, 2008
11. Ismail-Beigi F, Craven TE, O'Connor PJ, Karl D, Calles-Escandon J, Hramiak I, Genuth S, Cushman WC, Gerstein HC, Probstfield JL, Katz L, Schubart U; ACCORD Study Group: Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int 81: 586-594, 2012
12. Perkins BA, Krolewski AS: Early nephropathy in type 1 diabetes: The importance of early renal function decline. Curr Opin Nephrol Hypertens 18: 233-240, 2009
13. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT; Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559, 2008
14. Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD; ACCORD Study Group: Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods. Am J Cardiol 99[suppl]: 21i-33i, 2007
15. GinsbergHN, ElamMB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP; ACCORD Study Group: Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362: 1563-1574, 2010
16. CushmanWC, EvansGW, Byington RP, Goff DC Jr, GrimmRH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F; ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362: 1575-1585, 2010
17. Williamson JD, MillerME, Bryan RN, LazarRM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ; ACCORDStudy Group.: The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, design, and methods. Am J Cardiol 99:112i-122i, 2007
18. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, Sullivan M, Horowitz KR, Ding J, Marcovina S, Lovato LC, Lovato J, Margolis KL, O'Connor P, Lipkin EW, Hirsch J, Coker L, Maldjian J, Sunshine JL, Truwit C, Davatzikos C, Bryan RN; ACCORD MIND investigators: Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol 10: 969-977, 2011
19. Launer LJ, Oudkerk M, Nilsson LG, Alperovitch A, Berger K, Breteler MM, Fuhrer R, Giampaoli S, Nissinen A, Pajak A, Sans S, Schmidt R, Hofman A: CASCADE: A European collaborative study on vascular determinants of brain lesions. Study design and objectives. Neuroepidemiology 19: 113-120, 2000
20. Wechsler D: Wechsler Adult Intelligence Test-Revised, New York, Psychological Corporation, 1988
21. Hoyer WJ, Stawski RS, Wasylyshyn C, Verhaeghen P: Adult age and digit symbol substitution performance: A meta-analysis. Psychol Aging 19: 211-214, 2004
22. Lezak MD: Neuropsychological Assessment, 3rd Ed., New York, Oxford University Press, 1995
23. Houx PJ, Jolles J, Vreeling FW: Stroop interference: Aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 19: 209-224, 1993
24. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269: 2386-2391, 1993
25. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and theMDRDstudy equation for estimated glomerular filtration rate. JAMA 307: 1941-1951, 2012
26. Molenberghs G, Kenward M: Missing Data in Clinical Studies, Chichester, England, John Wiley and Sons Ltd, 2007
27. McCarthy I: The physiology of bone blood flow: A review. J Bone Joint Surg Am 88[Suppl 3]: 4-9, 2006
28. Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA: Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 38: 308-312, 2007
29. Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P: Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol 22: 2322-2331, 2011
30. Sattler C, Toro P, Schönknecht P, Schröder J: Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res 196: 90-95, 2012
31. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST; Report of the Quality Standards Subcommittee of the American Academy of Neurology: Practice parameter: early detection of dementia: Mild cognitive impairment (an evidencebased review). Neurology 56: 1133-1142, 2001
32. Proust-Lima C, Amieva H, Dartigues J-F, Jacqmin-Gadda H: Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. AmJ Epidemiol 165: 344-350, 2007
33. Spauwen PJJ, Köhler S, Verhey FRJ, Stehouwer CDA, van Boxtel MPJ: Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study. Diabetes Care 36: 1554-1561, 2013
34. Heringa SM, van den Berg E, Dekker JM, Nijpels G, Kessels RPC, Kappelle LJ, Stehouwer CDA, Biessels GJ: Albuminuria and cognitive functioning in an older population: The Hoorn study. Dement Geriatr Cogn Disord 32: 182-187, 2011
35. Jassal SK, Kritz-Silverstein D, Barrett-Connor E: A prospective study of albuminuria and cognitive function in older adults: The Rancho Bernardo study. Am J Epidemiol 171: 277-286, 2010
36. Weiner DE, Bartolomei K, Scott T, Price LL, Griffith JL, Rosenberg I, Levey AS, Folstein MF, Sarnak MJ: Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 53: 438-447, 2009
37. Joosten H, Izaks GJ, Slaets JPJ, de Jong PE, Visser ST, Bilo HJG, Gansevoort RT: Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol 6: 1400-1409, 2011
38. Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K: Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 16: 2127-2133, 2005
39. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH: Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 18: 2205-2213, 2007
40. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA: Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 73: 920-927, 2009
41. Etgen T, Sander D, Chonchol M, Briesenick C, Poppert H, Förstl H, Bickel H: Chronic kidney disease is associated with incident cognitive impairment in the elderly: The INVADE study. Nephrol Dial Transplant 24: 3144-3150, 2009
42. Helmer C, Stengel B, MetzgerM, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF: Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study. Neurology 77: 2043-2051, 2011